CRISPR Therapeutics (CRSP): next trial readout expected around 2028-07-01
$CRSP · CRISPR Therapeutics AGTrials that could report in the next 12 months: 1BiopharmaCTG
Catalyst timeline
Dates are estimated from each trial's registered completion date — none are FDA decision dates. Counts trials that fit our shared poll budget, not everything CRSP is running — see methodology.
- 2028-07-01in 97wA Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
Pipeline
| Program | Phase | Status | Primary completion | Trial |
|---|---|---|---|---|
| A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Part… | Phase 1 | Recruitingstill enrolling patients | 2028-07-01 | NCT07758634 |
| A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapse… | Phase 1 | Recruitingstill enrolling patients | NCT05643742 | |
| Safety and Preliminary Efficacy of CTX112 in Adult Participants With R… | Phase 1 | Recruitingstill enrolling patients | NCT07549698 | |
| A Safety and Tolerability Trial Evaluating CTX310 in Participants With… | Phase 1 | Recruitingstill enrolling patients | NCT07491172 |
Status-change history
Every ClinicalTrials.gov change recorded for CRSP's trials — a running history no other tracker shows.
No status changes detected yet for this ticker.
Frequently asked
When is CRSP's next PDUFA date?
No disclosed PDUFA date is currently tracked for this ticker.
What phase is CRSP's lead program in?
Phase 1 — recruiting.
Where does this data come from?
ClinicalTrials.gov v2 API (trial status + diffs) and company 8-K/press-release disclosures (PDUFA dates). Every number links to its source.